Anthony I Romer1, Lori Sussel. 1. Department of Genetics and Development, Columbia University, New York, New York, USA.
Abstract
PURPOSE OF REVIEW: This review will discuss recent advances in understanding mouse and human pancreatic islet cell development, novel concepts related to β cell dysfunction and improved approaches for replenishing β cells to treat diabetes. RECENT FINDINGS: Considerable knowledge about pancreatic islet development and function has been gained using model systems with subsequent validation in human tissues. Recently, several rodent studies have revealed that differentiated adult islet cells retain remarkable plasticity and can be converted to other islet cell types by perturbing their transcription factor profiles. Furthermore, significant advances have been made in the generation of β-like cells from stem cell populations. Therefore, the generation of functionally mature β cells by the in-situ conversion of non-β cell populations or by the directed differentiation of human pluripotent stem cells could represent novel mechanisms for replenishing β cells in diabetic patients. SUMMARY: The overall conservation between mouse and human pancreatic development, islet physiology and etiology of diabetes encourages the translation of novel β cell replacement therapies to humans. Further deciphering the molecular mechanisms that direct islet cell regeneration, plasticity and function could improve and expand the β cell replacement strategies for treating diabetes.
PURPOSE OF REVIEW: This review will discuss recent advances in understanding mouse and humanpancreatic islet cell development, novel concepts related to β cell dysfunction and improved approaches for replenishing β cells to treat diabetes. RECENT FINDINGS: Considerable knowledge about pancreatic islet development and function has been gained using model systems with subsequent validation in human tissues. Recently, several rodent studies have revealed that differentiated adult islet cells retain remarkable plasticity and can be converted to other islet cell types by perturbing their transcription factor profiles. Furthermore, significant advances have been made in the generation of β-like cells from stem cell populations. Therefore, the generation of functionally mature β cells by the in-situ conversion of non-β cell populations or by the directed differentiation of human pluripotent stem cells could represent novel mechanisms for replenishing β cells in diabeticpatients. SUMMARY: The overall conservation between mouse and humanpancreatic development, islet physiology and etiology of diabetes encourages the translation of novel β cell replacement therapies to humans. Further deciphering the molecular mechanisms that direct islet cell regeneration, plasticity and function could improve and expand the β cell replacement strategies for treating diabetes.
Authors: Farzad Esni; Bidyut Ghosh; Andrew V Biankin; John W Lin; Megan A Albert; Xiaobing Yu; Raymond J MacDonald; Curt I Civin; Francisco X Real; Michael A Pack; Douglas W Ball; Steven D Leach Journal: Development Date: 2004-07-27 Impact factor: 6.868
Authors: A Apelqvist; H Li; L Sommer; P Beatus; D J Anderson; T Honjo; M Hrabe de Angelis; U Lendahl; H Edlund Journal: Nature Date: 1999-08-26 Impact factor: 49.962
Authors: Chiara Greggio; Filippo De Franceschi; Manuel Figueiredo-Larsen; Samy Gobaa; Adrian Ranga; Henrik Semb; Matthias Lutolf; Anne Grapin-Botton Journal: Development Date: 2013-11 Impact factor: 6.868
Authors: Aiping Du; Chad S Hunter; Johanna Murray; Daniel Noble; Chen-Leng Cai; Sylvia M Evans; Roland Stein; Catherine Lee May Journal: Diabetes Date: 2009-06-05 Impact factor: 9.461
Authors: Jing Liu; Amrita Banerjee; Charles A Herring; Jonathan Attalla; Ruiying Hu; Yanwen Xu; Qiujia Shao; Alan J Simmons; Prasanna K Dadi; Sui Wang; David A Jacobson; Bindong Liu; Emily Hodges; Ken S Lau; Guoqiang Gu Journal: Dev Cell Date: 2019-01-07 Impact factor: 12.270
Authors: Nathalia Almeida; Matthew W H Chung; Elena M Drudi; Elise N Engquist; Eva Hamrud; Abigail Isaacson; Victoria S K Tsang; Fiona M Watt; Francesca M Spagnoli Journal: EMBO J Date: 2021-05-02 Impact factor: 14.012
Authors: Risheng Ye; Miao Wang; Qiong A Wang; Stephen B Spurgin; Zhao V Wang; Kai Sun; Philipp E Scherer Journal: Mol Metab Date: 2016-05-10 Impact factor: 7.422